Jiafan Sun

No ORCID on file · 4 papers in corpus
observational 2023
Efficacy and safety of dienogest versus GnRH-a combined with dienogest therapy for adenomyosis
·doi:10.21203/rs.3.rs-3509174/v1

Abstract Objective To investigate the efficacy and safety of dienogest((DNG) monotherapy and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment for adenomyosis. Methods This is a retrospective study.15…

meta-analysis 2023
Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis
Journal of ovarian research ·doi:10.1186/s13048-022-01084-z

OBJECTIVE: To explore the association between ovulation induction drugs and ovarian cancer. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Women without ovarian cancer who ever or never underwent ovaria…

2022
The Characteristics of Myofibroblasts and Pericytes in Endometriosis During Secretory Phase Revealed by Single-Cell RNA-Sequencing
·doi:10.2139/ssrn.4147538
other 2022
The heterogeneity of fibrosis and angiogenesis in endometriosis revealed by single-cell RNA-sequencing
Biochimica et biophysica acta. Molecular basis of disease ·doi:10.1016/j.bbadis.2022.166602

Fibrosis, angiogenesis and chronic inflammation are the inherent characteristics of endometriosis (EMS). The cellular heterogeneity of ectopic and non-ectopic endometrium by single-cell RNA-sequencing (scRNA-seq)at secretory phase without t…